More than seven million people die from tobacco every year. The molecule driving the addiction, nicotine, has never been subject to international drug control. Palau is moving to change that.
On 10 June 2026, the Republic of Palau formally notified the United Nations Secretary-General under Article 2 of the 1971 UN Convention on Psychotropic Substances, initiating a WHO critical review of nicotine.
Decades of tobacco control have saved millions of lives. But regulations follow the product, not the molecule, and the industry keeps creating new ways to deliver nicotine. Pouches, synthetic nicotine, and novel delivery systems each fall outside existing regulatory frameworks. Regulating nicotine addresses the problem at source.
The World Health Organization Expert Committee on Drug Dependence (WHO-ECDD) evaluates substances against four criteria: dependence potential, abuse risk, threat to public health, and therapeutic usefulness. The scientific case for reviewing nicotine appears to meet all four.
Palau's notification initiates a critical review by the WHO Expert Committee on Drug Dependence, a process expected to begin in late 2026. The Committee is expected to issue a recommendation by October 2027, ahead of a UN Commission on Narcotic Drugs vote targeted for March 2028.
- Government and general enquiries:
- contact@nicotinereview.org
- Media enquiries:
- media@nicotinereview.org